Abstract:Colorectal cancer (CRC) is one of the most common malignancies worldwide. The 5‐year survival rate of patients diagnosed with the early stages of the disease is markedly higher than that of patients in the advanced stages. Therefore, identifying novel biomarkers and drug targets for CRC is critical for clinical practice. Zinc finger protein 169 (ZNF169) is a crucial transcription factor, and its role in CRC remains to be explored. The present study aimed to investigate the clinical relevance, function and underlying mechanisms of ZNF169 in CRC growth and proliferation. The Cancer Genome Atlas (TCGA) database was utilized to analyze the clinical relevance of ZNF169 in patients with CRC. Immunohistochemical staining was performed on tissue samples from patients with CRC to detect the expression of ZNF169. The HCT‐116, HT‐29 and RKO cell lines were employed for in vitro experiments. The overexpression and knockdown of ZNF169 were achieved by transfecting the cells with lentivirus and small interfering RNAs, respectively. Cell Counting Kit‐8, colony formation and EdU staining assays were applied to investigate the function of ZNF169 in CRC cells. Dual luciferase activity and chromatin immunoprecipitation (ChIP)‐quantitative PCR (qPCR) assays were performed to identify the regulatory effects of ZNF169 on the ankyrin repeat and zinc‐finger domain‐containing 1 (ANKZF1; also known as ZNF744) gene. Reverse transcription‐quantitative PCR and western blot analysis were performed to measure mRNA and protein expression, respectively. The analysis of TCGA data revealed a positive correlation between ZNF169 and ANKZF1, with the overexpression of ANKZF1 being associated with a poor prognosis of patients with CRC. The experimental results demonstrated that ZNF169 was expression upregulated in CRC tissue compared with that in normal colon tissue. Gain‐of‐function and loss‐of‐function experiments revealed that ZNF169 enhanced the intensity of EdU staining, promoting the growth and proliferation of CRC cells. Furthermore, the overexpression of ZNF169 potentiated the transcriptional activity of the ANKZF1 gene, while the knockdown of ZNF169 produced the opposite results. ChIP‐qPCR confirmed the interaction between ZNF169 and the promoter sequence of ANKZF1. Rescue experiments revealed that ZNF169 accelerated CRC cell growth and proliferation through the upregulation of ANKZF1. Furthermore, there was a positive correlation identified between ZNF169 and ANKZF1, and upregulation of ANKZF1 expression was associated with the poor prognosis of patients with CRC. On the whole, the present study demonstrates that ZNF169 contributes to CRC malignancy by potentiating the expression of ANKZF1. Thus, the regulation of ZNF169 and/or ANKZF1 expression may represent a viable strategy for the treatment patients with CRC with a high expression of ZNF169.

Role of C9orf140 in the Promotion of Colorectal Cancer Progression and Mechanisms of Its Upregulation Via Activation of STAT5, Β-Catenin and EZH2.

Sa1693 the Role of C9orf140 in Colorectal Cancer Invasion

The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

LINC00265 Promotes Colorectal Tumorigenesis Via ZMIZ2 and USP7-mediated Stabilization of Β-Catenin

Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition

LINC00665 Activates Wnt/β-catenin Signaling Pathway to Facilitate Tumor Progression of Colorectal Cancer Via Upregulating CTNNB1.

Role of STAT 3 and Vitamin D Receptor in EZH 2-Mediated Invasion of Human Colorectal Cancer

Transcription factor ZEB1 coordinating with NuRD complex to promote oncogenesis through glycolysis in colorectal cancer

High Expression of SRSF10 Promotes Colorectal Cancer Progression by Aberrant Alternative Splicing of RFC5

C6orf15 Acts As a Potential Novel Marker of Adverse Pathological Features and Prognosis for Colon Cancer

LINC00543 promotes colorectal cancer metastasis by driving EMT and inducing the M2 polarization of tumor associated macrophages

Up-regulation of LINC00467 Promotes the Tumourigenesis in Colorectal Cancer.

C20orf27 Promotes Cell Growth and Proliferation of Colorectal Cancer Via the TGFβR-TAK1-NFĸB Pathway

Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1

Lncrna Casc15 Promotes Colon Cancer Cell Proliferation And Metastasis By Regulating The Mir-4310/Lgr5/Wnt/Beta-Catenin Signaling Pathway

YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis

LINC00365 promotes colorectal cancer cell progression through the Wnt/β‐catenin signaling pathway

LincROR Promotes Tumor Growth of Colorectal Cancer Through the Mir-145/Wnt2b/wnt10a/wnt/β-catenin Regulatory Axis

PI3K/AKT-mediated Upregulation of WDR5 Promotes Colorectal Cancer Metastasis by Directly Targeting ZNF407

Integrated systematic functional screen and fine-mapping decipher the role and genetic regulation of RPS19 in colorectal cancer development